FDA Approves Potentially Groundbreaking Schizophrenia Drug by Ed Cara from Gizmodo on 2024-09-27 15:50 (#6R2BA) On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb-the first truly novel treatment for schizophrenia in decades.
